Last reviewed · How we verify
Tetric N Bond Universal®
Tetric N Bond Universal® is a Small molecule drug developed by Liaquat University of Medical & Health Sciences. It is currently FDA-approved.
Tetric N Bond Universal is a restorative material used in dental procedures, specifically for treating cervical lesions and sensitivity in vital posterior teeth. It has been compared to other materials, including GC Fuji IX, in clinical trials to assess postoperative sensitivity.
At a glance
| Generic name | Tetric N Bond Universal® |
|---|---|
| Sponsor | Liaquat University of Medical & Health Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Postoperative Sensitivity Following Placement with Different Restorative Materials in Vital Posterior Teeth (PHASE4)
- Bioactive Restorative Material in Non-Carious Cervical Lesions (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tetric N Bond Universal® CI brief — competitive landscape report
- Tetric N Bond Universal® updates RSS · CI watch RSS
- Liaquat University of Medical & Health Sciences portfolio CI
Frequently asked questions about Tetric N Bond Universal®
What is Tetric N Bond Universal®?
Who makes Tetric N Bond Universal®?
What development phase is Tetric N Bond Universal® in?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing